Trade AstraZeneca PLC - GBP - AZNl CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.28 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02461% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002692% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.65 | ||||||||
| Currency | GBP | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 117.34 |
| Open | 117.28 |
| 1-Year Change | 7.39% |
| Day's Range | 116.82 - 117.28 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Oct 4, 2024 | 117.34 | -0.68 | -0.58% | 118.02 | 119.08 | 115.76 |
| Oct 3, 2024 | 119.46 | -0.73 | -0.61% | 120.19 | 120.69 | 119.06 |
| Oct 2, 2024 | 119.46 | 1.58 | 1.34% | 117.88 | 119.95 | 117.74 |
| Oct 1, 2024 | 117.56 | 1.12 | 0.96% | 116.44 | 117.72 | 115.54 |
| Sep 30, 2024 | 115.58 | -0.48 | -0.41% | 116.06 | 117.12 | 115.52 |
| Sep 27, 2024 | 115.20 | 0.28 | 0.24% | 114.92 | 117.18 | 114.92 |
| Sep 26, 2024 | 116.72 | -0.58 | -0.49% | 117.30 | 117.42 | 114.30 |
| Sep 25, 2024 | 115.42 | 1.08 | 0.94% | 114.34 | 115.70 | 112.82 |
| Sep 24, 2024 | 112.82 | -2.18 | -1.90% | 115.00 | 116.08 | 112.80 |
| Sep 23, 2024 | 115.40 | 0.40 | 0.35% | 115.00 | 117.24 | 115.00 |
| Sep 20, 2024 | 115.56 | -2.54 | -2.15% | 118.10 | 119.30 | 115.56 |
| Sep 19, 2024 | 118.76 | -0.42 | -0.35% | 119.18 | 120.25 | 118.52 |
| Sep 18, 2024 | 118.60 | -0.56 | -0.47% | 119.16 | 119.26 | 118.14 |
| Sep 17, 2024 | 119.70 | 0.37 | 0.31% | 119.33 | 120.95 | 119.02 |
| Sep 16, 2024 | 118.50 | -0.90 | -0.75% | 119.40 | 120.45 | 118.50 |
| Sep 13, 2024 | 119.09 | 0.26 | 0.22% | 118.83 | 119.32 | 116.84 |
| Sep 12, 2024 | 120.29 | -3.48 | -2.81% | 123.77 | 123.77 | 118.94 |
| Sep 11, 2024 | 120.61 | -1.86 | -1.52% | 122.47 | 123.35 | 120.61 |
| Sep 10, 2024 | 123.99 | 4.44 | 3.71% | 119.55 | 124.03 | 119.55 |
| Sep 9, 2024 | 126.53 | -0.20 | -0.16% | 126.73 | 126.85 | 124.27 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
AstraZeneca - GBP Company profile
About AstraZeneca plc
AstraZeneca PLC (AstraZeneca) is a patient-focused biopharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines, primarily for the treatment of diseases. The Company is focused on three main therapy areas: Oncology; Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development. The Company has access to technologies, both internally and through its various collaborations. Its technologies include acoustic tube technology, advanced molecular imaging, cryo-electron microscopy (cryo-EM), functional genomics, multi-omics and AstraZeneca iLab. The Company’s acoustic tube technology helps it to handle and process millions of compounds for biological screening. Its AstraZeneca iLab is its prototype of an automated medicinal chemistry laboratory.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, AstraZeneca plc revenues increased 41% to $37.42B. Net income decreased 96% to $112M. Revenues reflect Farxiga segment increase of 53% to $3B, Calquenc segment increase from $522M to $1.24B, Tagrisso segment increase of 16% to $5.02B, United States segment increase of 35% to $12.05B, United Kingdom segment increase of 86% to $3.25B, Sweden segment increase from $1.03B to $2.32B.
| Industry: | Pharmaceuticals (NEC) |
1 Francis Crick Avenue
CAMBRIDGE
CAMBRIDGESHIRE CB2 0AA
GB
News
September US Non-Farm Payrolls Preview
Kyle Rodda, Senior Market Analyst at Capital.com, previews the US Non-Farm Payrolls report for September. The article discusses market expectations of a stable labor market with 150,000 new jobs, an unchanged unemployment rate of 4.2%, and steady annual wage growth at 3.8%. It also highlights potential rate cuts by the Federal Reserve, revisions to past payroll data, and the reaction of various markets such as the US Dollar, S&P 500, and gold.
07:59, 2 October 2024
Market of the Month - Gold, an overview
In 2024, gold has been on an upward trajectory, hitting high after high as global markets face ongoing challenges. This precious metal, long seen as a safe haven, has been proving its worth, drawing attention from traders around the world as its bullish surge continues.
06:00, 30 September 2024
RBA Preview: Rates to remain unchanged with inflation-fighting still the focus
RBA Governor Michelle Bullock emphasizes inflation challenges for Australia's economy, citing supply shocks and demand-supply imbalances. Discover insights on CPI trends, interest rates, and the central bank's strategy for managing price pressures in 2024.
12:27, 20 September 2024
BoE Preview: no change expected but forward guidance will be key
The BoE is forecasted to leave rates unchanged in September as UK CPI remains stubborn.
14:53, 19 September 2024
FOMC Decision Review: A 50 point cut but the markets responded in a mixed fashion
Discover the US Federal Reserve’s latest 50 basis point cut and how the markets reacted. Stocks surged, the US Dollar fell, and the Fed hints at more aggressive cuts ahead.
11:30, 19 September 2024
Bank of Japan Preview
The Bank of Japan will meet on September 20, 2024, with markets anticipating minimal policy changes. However, inflation risks remain, with core CPI at 2.7% and potential for future interest rate hikes.
09:40, 17 September 2024
FOMC Decision Preview
As the US Federal Reserve prepares for its most significant decision since ending the rate hike cycle in mid-2023, the balance of risks has shifted. With inflation stabilizing at 2.6% and rising unemployment at 4.2%, the FOMC faces increasing pressure to address employment concerns. Markets anticipate a rate cut, with debate on the extent of the reduction.
09:48, 16 September 2024People also watch
Still looking for a broker you can trust?
Join the 650,000+ traders worldwide that chose to trade with Capital.com